We would love to hear your thoughts about our site and services, please take our survey here.
The critical Q is:
How do you intend to ensure the survival of the business as a going concern when none of the actions currently targeted by the BOD generate revenues before your cash runs out?
Appreciate people are interested in a broader set of topics, but you really need a factual question where the answer is in the hands of the BOD. Anything about trials, Poly/Tetra, covid market etc. will be batted off as external or speculation or confidential. Ask them about what is in their control, that they should reasonably have an answer for.
An EUA may be a technical possibility, but it seems very very unlikely from where we are.
Like a goal being scored by the keeper from a goal kick. It could happen, but the chances are very slim.
Much more realistic to believe that we may end up back in the game, with a credible path forward. That’s all I’m hoping for.
Like that goal kick found our midfielder and he has options to pass to the forwards.
Not sure why I’ve come over all JVT in my analogies this morning, but it feels like the probability of an EUA from a small failed trial needed some context!
I was pleased by the radio silence and the focus on smashing the numbers, and I hoped for a bumper trading RNS with confirmation of a stellar Chair being appointed.
I think ego has got in the way with this submission to the FCA.
What is he hoping for? A full blown enquiry will keep THG in negative news for the rest of the year and slaps on the wrist will do nothing but increase their determination to ruin him.
Seems this will run and run.
And do we expect to see a Chair named at them?
They’ve had long enough to recruit now and lots of big names will be attracted to the role.
Are these still set for the 18th?
Worth remembering that RMs words were something like that it would ‘trickle into 2022’ so they’re expecting just into the New Year
What a clown.
When are we expecting to find out how they did over the past week or so?
Next week?
Numbers
Zillah Byng Thorne is worth tens of millions. 50k shares is little more than a cheeky punt!
They only update them periodically.
They’ve sold a load now in case it falls further. Prudently managing their risks.
The other comment is very funny, the anonymous source basically says “we still believe in this, just half as much as we used to”
I noticed yesterday that my protein has a blanket 45% sale on so they’re either worried about sales or seeking to respond to this with bumper revenues in the run up to Christmas. Beauty will have good sales in this period anyway.
Is there a published date for the SoftBank option?
Feels like a millstone now as can’t happen because the price was fixed pre-crash so they’re never going to pay it.
Might be in THGs interests to get SoftBank to confirm that they won’t be taking it up now to clear the bad news out of the way rather than wait for it to become another cause for a downward spiral.
After an hour or so's further investigation. Ingenuity seems more akin to Amazon Web Services; built to meet the business's needs but then spun out to serve others. Clearly they're thinking it will take a similar position as the foundation of the business in the mid term. I see that as a massive opportunity to take a clip on others' sales and the margins should be strong as they're not taking any risk on volumes so probably won't be recognising the seller's product costs i.e. it will all be on fees.
From the analysts call I get the pushback on a lack of clarity on profitability but I did not feel it was the car crash it was described as being. I wonder if a lot of the sentiment is from hearing regional accents and not seeing faces which I always think is a mistake for a business seeking to build confidence.
The timing for entry (for me) seems good as they're heading into peak beauty sales period and they'll either prove the Ingenuity model with the massive scale in websites they're processing. The comment that Ingenuity will be able to fund ALL group CAPEX in future shows where they think this is going.
All IPO targets exceeded, upgrades to FY metrics and ingenuity as a burgeoning cash cow....what have I missed?
Seems oversold. I also think they'll let Ingenuity build to scale before carving off Beauty and Nutrition now. It feels like they got ahead of themselves in sharing that which is the difference between being a private management team and public business.
I've been looking into THG for a few weeks so new here. Seems they sell their own products (which I was aware of) but also host other firms on Ingenuity. Seems a cracking model. Almost a B2B Ebay.
What's the detail of the spin out of beauty and nutrition; were they included in the IPO and will now be spun out as separate entities? If so, would THG holders get shares in those entities and what is now THG would effectively become Ingenuity?
Activ 2 appears to be focussing on our favoured cohort of breathless patients. Our Home Trial was no targeted in that way.
If that plays out we may get higher efficacy in the A2 P3 than in we got in our P2.
Amazing. On the day we get the highest case numbers for three months!
Anecdotal I know, but I’ve taken my children for three tests since they went back to school a month ago. This week was the first time we had to queue to get into the test site.
But news isn’t news until it happens. There will be lots going on within the business but until milestones are hit or deals done they do not need to announce. There may well be something happening this week which they know is GOING to happen and therefore allows them to plan a session in advance.
Waterloo
I used to live in Aus so know a lot of people out there. The Aussie portion of my social media is like being transported back in time to March/April 2020. The same tensions, the same memes. Quite surreal really.